{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:40:17Z","timestamp":1775842817547,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.026","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T08:37:21Z","timestamp":1607848641000},"page":"460-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["BCG vaccine: Worrying proposal for COVID-19"],"prefix":"10.1016","volume":"39","author":[{"given":"Emanuel","family":"Sarinho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-9124","authenticated-orcid":false,"given":"Ekaterini","family":"Goudouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirceu","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.12.026_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.026_b0010","first-page":"375","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat RevImmunol"},{"issue":"02","key":"10.1016\/j.vaccine.2020.12.026_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2472-1093.100035","article-title":"Systematic Review of the Non-Specific Effects of Bacillus Calmette-Gu\u00e9rin Vaccine on Child Mortality","volume":"03","author":"Tavares Cruz","year":"2017","journal-title":"J Infectious Diseases Treatment"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.026_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jpids\/piy029","article-title":"BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial","volume":"8","author":"Stensballe","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"10","key":"10.1016\/j.vaccine.2020.12.026_b0025","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/ijms20102565","article-title":"Trained Innate Immunity Not Always Amicable","volume":"20","author":"Wlodarczyk","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.026_b0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/v12050505","article-title":"Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases","volume":"12","author":"Malinczak","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.026_b0035","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800191","article-title":"Infection History Determines Susceptibility to Unrelated Diseases","volume":"41","author":"Rakebrandt","year":"2019","journal-title":"BioEssays"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.026_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.12.026_b0045","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/all.14345","article-title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.026_b0050","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13312-020-1872-0","article-title":"Demystifying BCG Vaccine and COVID-19 Relationship","volume":"57","author":"Kumar","year":"2020","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2020.12.026_b0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?","volume":"11","author":"Covian","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.12.026_b0060","doi-asserted-by":"crossref","unstructured":"Berg MK, Yu k, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19. Sci Adv. 2020. Available from: https:\/\/advances.sciencemag.org\/content\/6\/32\/eabc1463 Access in 2 August 2020.","DOI":"10.1126\/sciadv.abc1463"},{"key":"10.1016\/j.vaccine.2020.12.026_b0065","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","author":"Escobar","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.026_b0070","first-page":"207","article-title":"Stop playing with data: there is no sound evidence that Bacille Calmette-Guerin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Ricco","year":"2020","journal-title":"Acta Biomed."},{"issue":"22","key":"10.1016\/j.vaccine.2020.12.026_b0075","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2020.12.026_b0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12098-020-03371-3","article-title":"BCG Vaccination Policy and Protection Against COVID-19","volume":"87","author":"Meena","year":"2020","journal-title":"Indian J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.026_b0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.13507","article-title":"Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination","volume":"202","author":"Aksu","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.12.026_b0090","unstructured":"Minist\u00e9rio da Sa\u00fade. BOLETIM EPIDEMIOL\u00d3GICO ESPECIAL-Doen\u00e7a pelo Coronav\u00edrus COVID-19 - Semana Epidemiol\u00f3gica 44 (25-31\/10). Brasil: Minist\u00e9rio da Sa\u00fade do Brasil; 2020. Available from: https:\/\/www.gov.br\/saude\/pt-br\/media\/pdf\/2020\/novembro\/13\/boletim_epidemiologico_covid_38_final_compressed.pdf\/ Access 25 November 2020."},{"key":"10.1016\/j.vaccine.2020.12.026_b0095","unstructured":"Center of Disease Control and Prevention COVID Data Tracker. Available from https:\/\/covid.cdc.gov\/covid-data-tracker\/index.html#demographics13. Access in 25 November 2020."},{"key":"10.1016\/j.vaccine.2020.12.026_b0100","unstructured":"Forbes India. News by Numbers: India's Covid-19 fatalities, by age. Available from https:\/\/www.forbesindia.com\/article\/news-by-numbers\/news-by-numbers-indias-covid19-fatalities-by-age\/63519\/1 Access 25 November 2020."},{"key":"10.1016\/j.vaccine.2020.12.026_b0105","unstructured":"National Health System. COVID-19 Daily Deaths. Available from: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/covid-19-daily-deaths\/ Access in 25 November 2020."},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.026_b0110","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"Dourado","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.026_b0115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","article-title":"Primary Immunodeficiency Diseases and Bacillus Calmette-Guerin (BCG)-Vaccine-Derived Complications: A Systematic Review","volume":"8","author":"Fekrvand","year":"2020","journal-title":"J Allergy Clin ImmunolIn practice"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:36Z","timestamp":1759402296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315930"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccine: Worrying proposal for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}